首页> 美国卫生研究院文献>ACS AuthorChoice >Multicolor Bioluminescence Boosts Malaria Research: Quantitative Dual-ColorAssay and Single-Cell Imaging in Plasmodium falciparum Parasites
【2h】

Multicolor Bioluminescence Boosts Malaria Research: Quantitative Dual-ColorAssay and Single-Cell Imaging in Plasmodium falciparum Parasites

机译:多色生物发光促进疟疾研究:定量双色恶性疟原虫寄生虫的含量测定和单细胞成像

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

New reliable and cost-effective antimalarial drug screening assays are urgently needed to identify drugs acting on different stages of the parasite Plasmodium falciparum, and particularly those responsible for human-to-mosquito transmission, that is, the P. falciparum gametocytes. Low Z′ factors, narrow dynamic ranges, and/or extended assay times are commonly reported in current gametocyte assays measuring gametocyte-expressed fluorescent or luciferase reporters, endogenous ATP levels, activity of gametocyte enzymes, or redox-dependent dye fluorescence. We hereby report on a dual-luciferase gametocyte assay with immature and mature P. falciparum gametocyte stages expressing red and green-emitting luciferases from Pyrophorus plagiophthalamus under the control of the parasite sexual stage-specific pfs16 gene promoter. The assay was validated with reference antimalarial drugs and allowed to quantitatively and simultaneously measure stage-specific drug effects on parasites at different developmental stages. The optimized assay, requiring only 48 h incubation with drugs and using a cost-effectiveluminogenic substrate, significantly reduces assay cost and time incomparison to state-of-the-art analogous assays. The assay had a Z′ factor of 0.71 ± 0.03, and it is suitablefor implementation in 96- and 384-well microplate formats. Moreover,the use of a nonlysing d-luciferin substrate significantlyimproved the reliability of the assay and allowed one to perform,for the first time, P. falciparum bioluminescenceimaging at single-cell level.
机译:迫切需要新的可靠且具有成本效益的抗疟药物筛选测定法,以鉴定作用于寄生虫恶性疟原虫不同阶段的药物,尤其是负责人与蚊传播的那些药物,即恶性疟原虫配子细胞。低Z'因子,狭窄的动态范围和/或延长的测定时间通常在当前的配子细胞测定中报告,该测定测量了配子细胞表达的荧光或萤光素酶报道分子,内源性ATP水平,配子细胞酶的活性或氧化还原依赖性染料荧光。我们在此报告双萤光素酶配子体试验,在寄生虫性阶段特异性pfs16基因启动子的控制下,用未成熟和成熟的恶性疟原虫恶性配子体阶段表达红色和绿色发光的萤光素酶。该测定方法已通过参考抗疟药进行了验证,并可以定量并同时测量不同发育阶段对寄生虫的阶段特异性药物作用。经过优化的测定方法,仅需与药物一起孵育48小时,即可使用具有成本效益的方法发光底物,显着降低了检测成本和时间与最新的类似方法进行比较。该测定的Z'因子为0.71±0.03,非常适合适用于96和384孔微孔板格式。此外,非裂解性d-荧光素底物的使用显着提高了测定的可靠性并允许其执行,第一次恶性疟原虫生物发光单细胞水平成像。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号